Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...

Beta2 (ß2)-agonist medications are a type of inhaled bronchodilator used ... Formoterol (found in Symbicort, Dulera, and as a ...

“The VA inhaler formulary change was carried out at the VA to save money given similar clinical efficacy data for Symbicort and Wixela Inhub, but we’re very interested to know the impact that ...